- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
- Paralegals
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
September 22, 2023Robins Kaplan Attorneys Named 2023 New York Super Lawyers and Rising Stars
-
September 12, 2023Annie Huang Receives Asian Leadership Award from Profiles in Diversity Journal
-
September 12, 2023Robins Kaplan Partners Named to 2024 Lawdragon 500 Leading Litigators in America Guide
-
September 26-28, 20236th Annual LF Dealmakers Forum
-
September 28-29, 20232023 Midwest IP Institute
-
October 4, 2023Lying, Cheating, and Stealing Seminar 2023
-
August 21, 2023Colorado Expands Antitrust Protection
-
July 18, 2023Copyright: Rights Even Heroes Can't Protect
-
August 2023Minnesota Bans Non-Competes Formed on or After July 1, 2023: Assessing Remaining Strategies to Protect Confidential Information and Trade Secrets
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Mylan Hit With $69.2M In Treble Damages
January 25, 2008
All Content Copyright 2007, Portfolio Media, Inc.
Blue Cross Blue Shield of Massachusetts and three other health insurance firms that opted out of a $35 million class-action settlement against Mylan Laboratories Inc. to pursue their own antitrust allegations have won a whopping $69.2 million award in treble damages.
Competition Law360
READ FULL ARTICLE Related Publications
September 26, 2018
February 10, 2015
July 15, 2013
Aventis Pharma., Inc. v. Amino Chemicals Ltd.
GENERICally Speaking Summer 2013
Related News
May 2, 2022
December 20, 2021
February 22, 2021
October 19, 2020
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.